Business Description
Founded in 2011 and headquartered in Beijing, AIM Vaccine Co. Ltd. is a Chinese company that creates and sells vaccines for a wide range of infectious diseases, serving both domestic and international markets. Its portfolio covers protection against conditions such as meningococcal disease, pneumonia, rabies, COVID-19, and several others, with multiple products currently progressing through clinical trials. The company is also advancing next-generation mRNA-based vaccines targeting diseases including shingles, rabies, and respiratory syncytial virus.
